M Naqvi
YOU?
Author Swipe
View article: INTEGRATED MANUFACTURING & SUPPLY CHAIN IN A PANDEMIC ENVIRONMENT
INTEGRATED MANUFACTURING & SUPPLY CHAIN IN A PANDEMIC ENVIRONMENT Open
View article: Structural Racism in Adverse Health Outcomes from Childhood Lead Exposure in Philadelphia
Structural Racism in Adverse Health Outcomes from Childhood Lead Exposure in Philadelphia Open
Childhood lead exposure poses a significant risk to health and well-being, adversely affecting brain function, nervous system development, and behavioral patterns. Sources of exposure, including dust, soil, consumer products, and water, co…
View article: Impact of Cachexia on Chemotherapy Efficacy and Survival in Pancreatic Cancer: A Systematic Review and Meta-Analysis
Impact of Cachexia on Chemotherapy Efficacy and Survival in Pancreatic Cancer: A Systematic Review and Meta-Analysis Open
Background and Objective Pancreatic cancer (PC) is a significant cause of cancer-related mortality, with limited curative options and high rates of cachexia, a debilitating syndrome associated with poor prognosis. While previous research h…
View article: P238 Longitudinal observation of patient engagement in an interstitial lung disease (ILD) home monitoring program
P238 Longitudinal observation of patient engagement in an interstitial lung disease (ILD) home monitoring program Open
Purpose To quantify patient engagement with a home-monitoring program designed to support clinical care of patients with interstitial lung diseases (ILD) in two NHS Trusts, in the South of England. Methods Patients with ILD who met eligibi…
View article: P224 Nintedanib in combination with immunosuppressant drug prescribing is safe and well tolerated in a large cohort of patients with progressive fibrotic interstitial lung disease
P224 Nintedanib in combination with immunosuppressant drug prescribing is safe and well tolerated in a large cohort of patients with progressive fibrotic interstitial lung disease Open
Introduction Nintedanib was approved by NICE for use in patients with progressive fibrotic ILD (PFILD) from February 2022. In the INBUILD trial, patients were excluded if they were treated with azathioprine, ciclosporin, mycophenolate mofe…
View article: S126 The pharmacist-led accelerated transfer of patients to shared care for the monitoring and prescribing of immunomodulatory therapy during covid-19
S126 The pharmacist-led accelerated transfer of patients to shared care for the monitoring and prescribing of immunomodulatory therapy during covid-19 Open
Introduction and Objectives Shared care allows for optimal local management of patients with support and guidance from the specialist secondary/tertiary care multidisciplinary teams. Implementing shared care for patients managed with immun…